Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G5SM
|
||||
Former ID |
DNC012919
|
||||
Drug Name |
HALOXYSTEROL A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527846] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H50O3
|
||||
Canonical SMILES |
CCC(CC(C(C)C1CCC2C1(CCC3C2CC=C4C3(C(CC(C4)O)O)C)C)O)C(C<br />)C
|
||||
InChI |
1S/C29H50O3/c1-7-19(17(2)3)14-26(31)18(4)23-10-11-24-22-9-8-20-15-21(30)16-27(32)29(20,6)25(22)12-13-28(23,24)5/h8,17-19,21-27,30-32H,7,9-16H2,1-6H3/t18-,19+,21+,22?,23+,24?,25?,26+,27-,28+,29-/m0/s1
|
||||
InChIKey |
UNBKHVKAEFBHAN-IWAMNEIESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [527846] | |
Acetylcholinesterase | Target Info | Inhibitor | [527846] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.